Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15226301rdf:typepubmed:Citationlld:pubmed
pubmed-article:15226301lifeskim:mentionsumls-concept:C0020792lld:lifeskim
pubmed-article:15226301lifeskim:mentionsumls-concept:C0023823lld:lifeskim
pubmed-article:15226301lifeskim:mentionsumls-concept:C0001128lld:lifeskim
pubmed-article:15226301lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:15226301lifeskim:mentionsumls-concept:C0005456lld:lifeskim
pubmed-article:15226301lifeskim:mentionsumls-concept:C0023688lld:lifeskim
pubmed-article:15226301lifeskim:mentionsumls-concept:C0220905lld:lifeskim
pubmed-article:15226301lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:15226301pubmed:issue37lld:pubmed
pubmed-article:15226301pubmed:dateCreated2004-9-6lld:pubmed
pubmed-article:15226301pubmed:abstractTextThe type V TGF-beta receptor (TbetaR-V) plays an important role in growth inhibition by IGFBP-3 and TGF-beta in responsive cells. Unexpectedly, TbetaR-V was recently found to be identical to the LRP-1/alpha(2)M receptor; this has disclosed previously unreported growth regulatory functions of LRP-1. Here we demonstrate that, in addition to expressing LRP-1, all cells examined exhibit low affinity but high density acidic pH binding sites for LRP-1 growth regulatory ligands (TGF-beta(1), IGFBP-3, and alpha(2)M(*)). These sites, like LRP-1, are sensitive to receptor-associated protein and calcium depletion but, unlike LRP-1, are also sensitive to chondroitin sulfate and heparin and capable of directly binding ligands, which do not bind to LRP-1. Annexin VI has been identified as a major membrane-associated protein capable of directly binding alpha(2)M(*) at acidic pH. This is evidenced by: 1) structural and Western blot analyses of the protein purified from bovine liver plasma membranes by alpha(2)M(*) affinity column chromatography at acidic pH, and 2) dot blot analysis of the interaction of annexin VI and (125)I-alpha(2)M(*). Cell surface annexin VI is involved in (125)I-TGF-beta(1) and (125)I-alpha(2)M(*) binding to the acidic pH binding sites and (125)I-alpha(2)M(*) binding to LRP-1 at neutral pH as demonstrated by the sensitivity of cells to pretreatment with anti-annexin VI IgG. Cell surface annexin VI is also capable of mediating internalization and degradation of cell surface-bound (125)I-TGF-beta(1) and (125)I-alpha(2)M(*) at pH 6 and of forming ternary complexes with (125)I-alpha(2)M(*) and LRP-1 at neutral pH as demonstrated by co-immunoprecipitation. Trifluoperazine and fluphenazine, which inhibit ligand binding to the acidic pH binding sites, block degradation after internalization of cell surface-bound (125)I-TGF-beta(1) or (125)I-alpha(2)M(*). These results suggest that cell surface annexin VI may function as an acidic pH binding site or receptor and may also function as a co-receptor with LRP-1 at neutral pH.lld:pubmed
pubmed-article:15226301pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15226301pubmed:languageenglld:pubmed
pubmed-article:15226301pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15226301pubmed:citationSubsetIMlld:pubmed
pubmed-article:15226301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15226301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15226301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15226301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15226301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15226301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15226301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15226301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15226301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15226301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15226301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15226301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15226301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15226301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15226301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15226301pubmed:statusMEDLINElld:pubmed
pubmed-article:15226301pubmed:monthSeplld:pubmed
pubmed-article:15226301pubmed:issn0021-9258lld:pubmed
pubmed-article:15226301pubmed:authorpubmed-author:ChenChun-LinC...lld:pubmed
pubmed-article:15226301pubmed:authorpubmed-author:HuangJung...lld:pubmed
pubmed-article:15226301pubmed:authorpubmed-author:LingThai-YenT...lld:pubmed
pubmed-article:15226301pubmed:authorpubmed-author:HuangShuan...lld:pubmed
pubmed-article:15226301pubmed:authorpubmed-author:HuangYen-HuaY...lld:pubmed
pubmed-article:15226301pubmed:authorpubmed-author:LiuI-HuaIHlld:pubmed
pubmed-article:15226301pubmed:issnTypePrintlld:pubmed
pubmed-article:15226301pubmed:day10lld:pubmed
pubmed-article:15226301pubmed:volume279lld:pubmed
pubmed-article:15226301pubmed:ownerNLMlld:pubmed
pubmed-article:15226301pubmed:authorsCompleteYlld:pubmed
pubmed-article:15226301pubmed:pagination38736-48lld:pubmed
pubmed-article:15226301pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:meshHeadingpubmed-meshheading:15226301...lld:pubmed
pubmed-article:15226301pubmed:year2004lld:pubmed
pubmed-article:15226301pubmed:articleTitleIdentification and characterization of the acidic pH binding sites for growth regulatory ligands of low density lipoprotein receptor-related protein-1.lld:pubmed
pubmed-article:15226301pubmed:affiliationInstitute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.lld:pubmed
pubmed-article:15226301pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15226301pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:15226301pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:2entrezgene:pubmedpubmed-article:15226301lld:entrezgene
entrez-gene:4035entrezgene:pubmedpubmed-article:15226301lld:entrezgene
entrez-gene:309entrezgene:pubmedpubmed-article:15226301lld:entrezgene
entrez-gene:11749entrezgene:pubmedpubmed-article:15226301lld:entrezgene
entrez-gene:16971entrezgene:pubmedpubmed-article:15226301lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15226301lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15226301lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15226301lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15226301lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15226301lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15226301lld:pubmed